BackAnthera Pharmaceuticals Overview

Anthera Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ANTH.

Quarterly EBIT

-$7.68M
↑ 30.22% YoY

As of Mar 31, 2018

Annual EBIT (TTM)

-$23.27M
↑ 57.63% YoY

Trailing 12 months ending Mar 31, 2018

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin